The East African Community produces only less than 30 per cent of the medicines it needs while it imports the rest, a situation that must be reversed to ensure citizens easily access affordable drugs, officials have said. This revelation was made last week during the launch of a 10-year strategic plan for pharmaceutical manufacturing at the EAC seat in Arusha, Tanzania. The launch was held on the margins of the first regional vaccine production symposium. “Vaccines are among a category of medicines that the region wholly depends on imports as currently there is no local production capacity. There is a vacuum and nature hates vacuum,” said Kirunda Kivejinja, the chairperson of the EAC Council of Ministers. Kivejinja is also Uganda’s second deputy prime minister and minister for East African Community affairs. “We are determined to reverse these negative trends and strengthen local production capacity,” he said, noting that the 2017-2027 roadmap seeks to address this issue. According to Christophe Bazivamo, the deputy EAC secretary-general for productive sectors, the action plan will guide the bloc towards evolving into an efficient and effective pharmaceutical industry. The bloc views the local production of essential medicines as contributing to attaining sustainable development goal (SDG) 3.8 – achievement of universal health coverage, including financial risk protection, access to quality essential health care services, and access to safe, effective, quality and affordable essential medicines and vaccines for all – in a more sustainable manner than through delivery of donated drugs to developing countries. “I am happy...
EAC unveils plan to bridge drugs manufacturing gap
Posted on: April 23, 2018
Posted on: April 23, 2018